Related Experiment Video
Updated: May 23, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
C-reactive protein and P-wave in hypertensive patients after conversion of atrial fibrillation
Andrea Mazza1, Maria G Bendini, Marco Cristofori
1Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.
Insights
High-sensitivity C-reactive protein (hs-C-reactive protein) is linked to prolonged P-wave duration and dispersion in hypertensive patients post-atrial fibrillation conversion. This suggests subclinical inflammation may impact atrial activation.
Area of Science:
- Cardiology
- Electrophysiology
- Inflammation Markers
Background:
- Atrial fibrillation recurrence is a clinical concern.
- P-wave duration and dispersion are ECG markers of atrial activation.
- High-sensitivity C-reactive protein (hs-C-reactive protein) is an inflammation marker.
Purpose of the Study:
- To investigate the association between hs-C-reactive protein and P-wave parameters (P maximum/P dispersion) in hypertensive patients after atrial fibrillation conversion.
- To determine if hs-C-reactive protein can predict delayed or inhomogeneous atrial activation.
Main Methods:
- 92 hypertensive patients undergoing cardioversion for atrial fibrillation were enrolled.
- Hs-C-reactive protein levels were measured before cardioversion.
- 12-lead ECGs were recorded immediately after sinus rhythm restoration to assess P-wave duration and dispersion.
Main Results:
- Elevated hs-C-reactive protein (>0.30 mg/dl) was significantly associated with increased P maximum (>120 ms) and P dispersion (>40 ms) in univariate and multivariate analyses.
- Male sex was also associated with increased P maximum.
- Hs-C-reactive protein was the sole predictor for increased P dispersion in multivariate analysis.
Conclusions:
- Hs-C-reactive protein is associated with prolonged P-wave duration and dispersion in hypertensive patients post-atrial fibrillation conversion.
- Subclinical inflammation, indicated by hs-C-reactive protein, may contribute to delayed and inhomogeneous atrial activation in these patients.
- These findings highlight the potential role of inflammation in atrial remodeling and dysfunction.
Aims:
P maximum/P dispersion and high-sensitivity C-reactive protein (hs-C-reactive protein) have been proposed as useful markers for predicting the history and recurrence of atrial fibrillation. We tested the association between hs-C-reactive protein and maximum P-wave duration (P maximum)/P-wave dispersion (P dispersion) in hypertensive patients after conversion of atrial fibrillation.
Methods:
We enrolled 92 patients. Hs-C-reactive protein was assessed before cardioversion, the 12-lead ECG was recorded immediately after sinus rhythm restoration.
Results:
At univariate analysis P maximum above 120 ms was associated with male sex (P = 0.0009), body mass index at least 25 kg/m (P = 0.03) and hs-C-reactive protein greater than 0.30 mg/dl (P = 0.0001), and left atrium diameter greater than 40 mm nearly significant (P = 0.05). P dispersion above 40 ms was associated with hs-C-reactive protein greater than 0.30 mg/dl (P = 0.0001) and left atrium diameter greater than 0.40 mm (P = 0.03). P maximum/P dispersion (mean ± SD) was significantly longer in patients with hs-C-reactive protein greater than 0.30 mg/dl compared to patients with hs-C-reactive protein 0.30 mg/dl or less (P = 0.0001 for both). At multivariate analysis P maximum above 120 ms was associated with male sex (P = 0.01) and with hs-C-reactive protein greater than 0.30 mg/dl (P = 0.002), whereas P dispersion above 40 ms was associated only with hs-C-reactive protein greater than 0.30 mg/dl (P = 0.0006).
Conclusion:
Male sex and hs-C-reactive protein were associated with P maximum above 120 ms; hs-C-reactive protein was also associated with P dispersion above 40 ms in hypertensive patients after conversion of atrial fibrillation. Subclinical inflammation may be associated with delayed/inhomogeneous atrial activation in hypertensive patients affected by atrial fibrillation.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
